Mathieu Ceccaldi
Overview
Explore the profile of Mathieu Ceccaldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
2814
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
[Overview of the French Memory Centres healthcare pathway for patients with early Alzheimer disease]
Ceccaldi M, Monteil-Hautin V, Chevrette A, Lebouvier T, Lefrancois M, Wallon D, et al.
Geriatr Psychol Neuropsychiatr Vieil
. 2025 Jan;
22(3):372-379.
PMID: 39840421
The growing prevalence of the Alzheimer's disease (AD) is an increasing public health concern that led to French recommendations for timely AD diagnosis and patient management as well as a...
2.
Lespinasse J, Chene G, Mangin J, Dubois B, Blanc F, Paquet C, et al.
Alzheimers Dement
. 2022 Dec;
19(6):2332-2342.
PMID: 36464896
Introduction: Approximately 40% of dementia cases could be delayed or prevented acting on modifiable risk factors including hypertension. However, the mechanisms underlying the hypertension-dementia association are still poorly understood. Methods:...
3.
Planche V, Bouteloup V, Pellegrin I, Mangin J, Dubois B, Ousset P, et al.
Neurology
. 2022 Oct;
100(5):e473-e484.
PMID: 36261295
Background And Objective: Blood biomarkers for Alzheimer disease (AD) have consistently proven to be associated with CSF or PET biomarkers and effectively discriminate AD from other neurodegenerative diseases. Our aim...
4.
Blanc F, Bouteloup V, Paquet C, Chupin M, Pasquier F, Gabelle A, et al.
Alzheimers Res Ther
. 2022 Jul;
14(1):96.
PMID: 35854388
Background: Isolated subjective cognitive impairment (SCI) and mild cognitive impairment (MCI) are the prodromal phases of dementia with Lewy bodies (DLB). MEMENTO is a nationwide study of patients with SCI...
5.
Grasset L, Proust-Lima C, Mangin J, Habert M, Dubois B, Paquet C, et al.
Alzheimers Res Ther
. 2022 May;
14(1):68.
PMID: 35585559
Background: This work aimed to investigate the potential pathways involved in the association between social and lifestyle factors, biomarkers of Alzheimer's disease and related dementia (ADRD), and cognition. Methods: The...
6.
Guedj E, Campion J, Horowitz T, Barthelemy F, Cammilleri S, Ceccaldi M
Hum Brain Mapp
. 2021 Oct;
43(2):593-597.
PMID: 34636103
This study aims to evaluate the impact of French national lockdown of 55 days on brain metabolism of patients with neurological disorders. Whole-brain voxel-based PET analysis was used to correlate...
7.
Frison E, Proust-Lima C, Mangin J, Habert M, Bombois S, Ousset P, et al.
Neurology
. 2021 Jul;
97(8):e836-e848.
PMID: 34210821
Objective: To assess the role of biomarkers of Alzheimer disease (AD), neurodegeneration, and small vessel disease (SVD) as mediators in the association between diabetes mellitus and cognition. Methods: The study...
8.
Guedj E, Morbelli S, Kaphan E, Campion J, Dudouet P, Ceccaldi M, et al.
Brain
. 2021 Jun;
144(8):e65.
PMID: 34142116
No abstract available.
9.
Guedj E, Lazarini F, Morbelli S, Ceccaldi M, Hautefort C, Kas A, et al.
Clin Microbiol Infect
. 2021 May;
27(9):1196-1198.
PMID: 34015528
No abstract available.
10.
Chamberlain J, Rouanet A, Dubois B, Pasquier F, Hanon O, Gabelle A, et al.
Alzheimers Dement
. 2021 Mar;
17(9):1415-1421.
PMID: 33656287
Introduction: Studies on the association of cancer and risk of dementia are inconclusive due to result heterogeneity and concerns of survivor bias and unmeasured confounding. Methods: This study uses data...